The COVID-19 virus is spreading across the world, which is affecting more than 190 countries and territories according to WHO’s report on March 22, 2020. Many countries are working on effective measurements for preventing the infection such as suggesting washing hands and wearing the mask, but since the disease is extremely contagious and treatment and vaccine are still on the clinical trial, early prevention and diagnosis are essential at the current moment.

In response to the coronavirus pandemic globally, YHLO is offering medical products to different countries to help mitigate the outbreak. Since this February, YHLO has donated SARS-CoV-2 IgM and IgG CLIA kits, medical/surgical masks and protective suits to over 20 countries including Italy, Germany, Greece, United States, Australia, India, Iran, Yemen, Thailand and Sweden.

 

YHLO's SARS-CoV-2 IgM and IgG CLIA kits, developed during the Wuhan outbreak, have demonstrated excellent performance in a number of hospitals, with advantages of fast speed, high sensitivity and specificity, strong anti-interference ability. With the matching systems——fully automated chemiluminescence analyzer iFlash 1800 / iFlash 3000, YHLO’s SARS-CoV-2 solution is able to offer a safe and efficient way for hospitals and laboratories to aid diagnosis of COVID-19, which is also a valuable supplementary tool for RT-PCR, especially for patients with negative RT-PCR results to rule out false negative.

One world, one destiny! Only through global collaboration can the war against the virus eventually be won. YHLO will continue its efforts toward the mission “focus on healthcare, better life with technology”.